Magnetically engineered SnO2 quantum dots as a bimodal agent for optical and magnetic resonance imaging

Abstract

Combining more than one imaging technique into a single system can outweigh the limitations of conventional imaging techniques. Pairing optically active quantum dots (QDs) with superparamagnetic MRI agent is an adorable way to develop probes for bimodal imaging. Tiny SnO2 quantum dot embedded iron oxide (IO) nanocomposite (SQD-IO) is synthesized. This combines the superparamagnetic property of IO nanoparticles (NPs) and special optical properties of SnO2 QDs, and is explored as a bimodal imaging agent. Morphological studies of the nanocomposite reveal that 3 nm tiny SnO2 QDs are embedded in ~30 nm γ-Fe2O3 NPs. The SQD-IO preserves the intrinsic superparamagnetic behaviour of its constituent IO NPs with a magnetization ~21.4 emu g−1 measured at an applied field of 20k Oe. The emission colour of the nanocomposite is tuned by simply varying the excitation wavelength. The centre of the emission band shifts from 570 to 600 nm as the excitation alters from 488 to 535 nm. The cytotoxicity assessment indicates that the nanocomposite is suitable for its in vitro use. Transverse proton relaxivity (141 mM−1 s−1) of the nanocomposite is higher than the widely used negative contrast agent Feridex (R2 = 98.3 mM−1 s−1). The confocal laser scanning microscope images give evidence of the cellular uptake behaviour of SQD-IO in HeLa cells and it is seen that QDs retain their optical properties within the intracellular environment. The high R2 value for MRI and the tunable florescence images of HeLa cells essentially establish SQD-IO as a potential probe for bimodal imaging.